The Attitudes and Beliefs of Hispanic/Latino Individuals Toward Prescription Opioids and Non-Medical Opioid Use

NCT05529082 | Withdrawn

• 2 other identifiers: 2022-0543NCI-2022-06839
• Study Type: observational
• Target: N/A
• Locations: 1 country
• Sites: 1

Brief Summary

To better understand how people think and feel about prescribed pain medication, including opioids.

Conditions

Opioids

Outcome Measures

Primary Outcomes (1)

• Opioid Attitudes and Beliefs Survey

  The survey questionnaire consists of a total of 33 items in five brief sections and responses are mainly based on a 5-point Likert scale ranging from "strongly disagree" to "strongly agree".

  through completion of study an average of 1 year

Study Arms (1)

Opioid Attitudes and Beliefs survey

Participants will complete a questionnaire about your feelings/beliefs on prescription pain medication and your experience with opioids/pain medication. Demographic information about you (such as your age, gender, race, ethnicity, and so on) will also be collected.

Other: Opioid Attitudes; Other: Beliefs survey

Interventions

Opioid Attitudes OTHER

Participants will complete a questionnaire about your feelings/beliefs on prescription pain medication and your experience with opioids/pain medication. Demographic information about you (such as your age, gender, race, ethnicity, and so on) will also be collected.

Opioid Attitudes and Beliefs survey

Beliefs survey OTHER

Participants will complete a questionnaire about your feelings/beliefs on prescription pain medication and your experience with opioids/pain medication. Demographic information about you (such as your age, gender, race, ethnicity, and so on) will also be collected.

Opioid Attitudes and Beliefs survey

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

M D Anderson Cancer Center

You may qualify if:

• Aged 18 years or older.
• Ability to understand, read, write, or speak English and/or Spanish.
• Ability to give informed consent.
• Willingness to participate in the survey.

You may not qualify if:

• \. Refusal to participate in the study

Sponsors & Collaborators

• M.D. Anderson Cancer Center: lead
• National Institutional of Health: collaborator
• UT Health Science Center: collaborator

Study Sites (1)

M D Anderson Cancer Center

Houston, Texas, 77030, United States

Location

Related Links

• M D Anderson Cancer Center

Study Officials

• Joseph Arthur, MD

  M.D. Anderson Cancer Center

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: September 1, 2022
• First Posted: September 6, 2022
• Study Start: March 23, 2023
• Primary Completion: July 30, 2024
• Study Completion: July 30, 2024
• Last Updated: August 2, 2024

Record last verified: 2024-07

Locations

US (1)